Akoya Biosciences, Inc.
DelistedCIK 1711933fmd_1HJ4N1J0PX2GF3AH7GEMTAW8YVManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Mar 31, 2025, 21 periods
Latest annual · FY2024
Millions- Total revenues
- 82
- Gross profit
- 48
- Operating income
- (47)
- Net income
- (55)
- Free cash flow
- (47)
Latest quarter · Q1 FY2025
Millions- Total revenues
- 17
- Gross profit
- 10
- Operating income
- (13)
- Net income
- (16)
- Free cash flow
- (7)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +14.1%
Akoya Biosciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $81.7 million | $96.6 million | -15.5% | 10-K 2025-03-17 · proof |
| Gross profit | $47.9 million | $56.3 million | -15% | 10-K 2025-03-17 · proof |
| Operating income | -$46.7 million | -$57.7 million | 10-K 2025-03-17 · proof | |
| Net income | -$55.4 million | -$63.3 million | 10-K 2025-03-17 · proof | |
| Cash from operating activities | -$44.1 million | -$50.9 million | 10-K 2025-03-17 · proof | |
| Free cash flow | -$46.6 million | -$54.6 million | 10-K 2025-03-17 · proof | |
| Total assets | $125 million | $180.4 million | -30.7% | 10-K 2025-03-17 · proof |
| Total liabilities | $117.4 million | $126.6 million | -7.3% | 10-K 2025-03-17 · proof |
| Cash and cash equivalents | $11.8 million | $83.1 million | -85.8% | 10-K 2025-03-17 · proof |
- What was Akoya Biosciences, Inc.'s revenue in fiscal 2024?
- Akoya Biosciences, Inc. reported revenue of $81.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $96.6 million the year before (-15.5%). Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What was Akoya Biosciences, Inc.'s gross profit in fiscal 2024?
- Akoya Biosciences, Inc. reported gross profit of $47.9 million for fiscal 2024 (the year ended Dec 31, 2024), against $56.3 million the year before (-15%). Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What was Akoya Biosciences, Inc.'s operating income in fiscal 2024?
- Akoya Biosciences, Inc. reported operating income of -$46.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$57.7 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What was Akoya Biosciences, Inc.'s net income in fiscal 2024?
- Akoya Biosciences, Inc. reported net income of -$55.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$63.3 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What was Akoya Biosciences, Inc.'s cash from operating activities in fiscal 2024?
- Akoya Biosciences, Inc. reported cash from operating activities of -$44.1 million for fiscal 2024 (the year ended Dec 31, 2024), against -$50.9 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What was Akoya Biosciences, Inc.'s free cash flow in fiscal 2024?
- Akoya Biosciences, Inc. reported free cash flow of -$46.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$54.6 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What are Akoya Biosciences, Inc.'s total assets?
- As of Dec 31, 2024, Akoya Biosciences, Inc. reported total assets of $125 million, against $180.4 million a year earlier (-30.7%). Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What are Akoya Biosciences, Inc.'s total liabilities?
- As of Dec 31, 2024, Akoya Biosciences, Inc. reported total liabilities of $117.4 million, against $126.6 million a year earlier (-7.3%). Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
- What are Akoya Biosciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, Akoya Biosciences, Inc. reported cash and cash equivalents of $11.8 million, against $83.1 million a year earlier (-85.8%). Source: the 10-K filed with the SEC on Mar 17, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1711933&period_type=annual&limit=5"Information only, not investment advice.